New Two-in-One diabetes drug put to the test
NCT ID NCT06403761
Summary
This study tested a new investigational drug called CagriSema, which combines two medicines, to see how it helps the body use insulin in people with type 2 diabetes. 158 participants, who were already taking metformin, received either CagriSema, one of its components, or a placebo for about 42 weeks. The main goal was to measure changes in how well the body responds to insulin and how the pancreas functions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.